ResMed Inc (STU:RME)
€ 238 -0.2 (-0.08%) Market Cap: 33.56 Bil Enterprise Value: 33.96 Bil PE Ratio: 32.69 PB Ratio: 6.97 GF Score: 98/100

Resmed Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 10, 2020 / 10:00PM GMT
Release Date Price: €179 (-0.56%)
Gretel Janu;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

All right. Hi, everyone. So my name is Gretel Janu. So I've got here, Mick Farrell, CEO of ResMed; and Dave Pendarvis, CAO of ResMed.

So Mick, David, thank you very much for your time today for joining our conference. Now it's great to have you here virtually.

Questions & Answers

Gretel Janu;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

So I think to start us off, Mick, do you want to start off to give us an update as to how the business has performed during COVID? A quick highlight of the latest results, given they were just a couple of weeks ago, and then we'll jump into some of the questions.

Michael J. Farrell
ResMed Inc. - CEO & Director

Yes. Sounds good, Gretel. I'll do just a very brief maybe 3-minute intro, and then allow the bulk of the time, Gretel, for you to facilitate Q&A from the team that's on.

So look, incredible 2020 here with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot